News FocusCancer Research

Taking Garbage In, Tossing Cancer Out?

Science  25 Jan 2002:
Vol. 295, Issue 5555, pp. 612-613
DOI: 10.1126/science.295.5555.612

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Cancer drugs, with few exceptions, go after predictable targets: DNA replication (cisplatin), microtubules (Taxol), growth signaling pathways (Gleevec), and angiogenesis (for example, endostatin). Now a new class of compounds that work in a novel way--blocking the cell's garbage disposal, or proteasome--is showing promise in clinical trials, although their mechanism of action is complex and still poorly understood.

Related Content